Table 1.
Demographic Distribution of Patients With Long-Term Use of Stimulants, Opioids, or Benzodiazepines
| Characteristic | Stimulants No. (%) | Opioids No. (%) | Benzodiazepines No. (%) |
|---|---|---|---|
| Total No. | 9,014 | 78,056 | 31,437 |
| Age, y | |||
| 18-44 | 4,648 (51.6) | 13,850 (17.7) | 5,972 (19.0) |
| 45-54 | 1,888 (21.0) | 17,724 (22.7) | 7,257 (23.1) |
| 55-64 | 1,807 (20.1) | 24,371 (31.2) | 9,858 (31.4) |
| ≥65 | 671 (7.4) | 22,111 (28.3) | 8,350 (26.6) |
| Locationa | |||
| Urban | 6,541 (72.6) | 43,696 (56.0) | 18,547 (59.0) |
| Rural | 2,317 (25.7) | 32,949 (42.2) | 12,454 (39.6) |
a
Excludes 1,411 (1.8%) non-Oregon and unknown patients with long-term use of opioids, 156 (1.7%) stimulants, and 436 (1.4%) benzodiazepines.